Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 7001-7050 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT05627011
Dissemination and Implementation of Improving Pediatric Obesity Practice Using Prompts
NA
Active, not recruiting
240,772 participants
Started: Feb 9, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
3 locations
NCT05501054
Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Feb 9, 2023 · Completed: Nov 1, 2026
1 condition
1 sponsor
3 locations
NCT05659927
Single Dose Clinical Trial of MG-ZG122 in Chinese Healthy Adult Subjects
PHASE1
Active, not recruiting
34 participants
Started: Feb 9, 2023 · Completed: Mar 23, 2024
1 condition
1 sponsor
1 location
NCT05715307
Chinese Endocrinologists Health Education Study
NA
Active, not recruiting
2,017 participants
Started: Feb 9, 2023 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT04718792
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
PHASE2
Active, not recruiting
10 participants
Started: Feb 9, 2023 · Completed: Jul 21, 2024
1 condition
2 sponsors
1 location
NCT05577026
Safe Prescription of Opioids in Primary Care
NA
Active, not recruiting
52 participants
Started: Feb 9, 2023 · Completed: Mar 31, 2027
3 conditions
1 sponsor
1 location
NCT04959929
Wearable Focal Vibration for Chemotherapy-Induced Peripheral Neuropathy
NA
Active, not recruiting
15 participants
Started: Feb 9, 2023 · Completed: Jul 1, 2025
1 condition
1 sponsor
1 location
NCT05854017
Effects of a Theanine for Stress Relief Formulation in Individuals Who Report Occasional Moderate High Levels of Stress.
NA
Active, not recruiting
104 participants
Started: Feb 9, 2023 · Completed: Aug 20, 2025
1 condition
1 sponsor
1 location
NCT05702658
The Effectiveness of an Autistic-delivered Peer-support Intervention for Autistic Adults: Community Autism Peer Specialist (CAPS) Program
NA
Active, not recruiting
40 participants
Started: Feb 9, 2023 · Completed: Aug 31, 2025
1 condition
3 sponsors
1 location
NCT05621317
A Safety and Efficacy Study of PVX108 in Children and Adolescents With Peanut Allergy
PHASE2
Active, not recruiting
90 participants
Started: Feb 9, 2023 · Completed: Jun 30, 2027
4 conditions
1 sponsor
14 locations
NCT05714748
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors
PHASE1
Active, not recruiting
19 participants
Started: Feb 8, 2023 · Completed: May 31, 2025
1 condition
1 sponsor
1 location
NCT05731271
A First-in-Human, Phase 1 Study of TST003 in Subjects With Solid Tumors
PHASE1/PHASE2
Active, not recruiting
111 participants
Started: Feb 8, 2023 · Completed: Aug 31, 2025
3 conditions
1 sponsor
3 locations
NCT03820687
Improving Informed Decision Making for Cancer Clinical Trial Participation
NA
Active, not recruiting
581 participants
Started: Feb 8, 2023 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT04882475
Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
N/A
Active, not recruiting
160 participants
Started: Feb 8, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
16 locations
NCT05500443
The DANish COronary DEcalcification (DANCODE) Trial
NA
Active, not recruiting
400 participants
Started: Feb 8, 2023 · Completed: Nov 30, 2029
1 condition
1 sponsor
3 locations
NCT05706909
The Use of Genex in the Management of Early-Stage Osteonecrosis of the Femoral Head
N/A
Active, not recruiting
22 participants
Started: Feb 8, 2023 · Completed: Jul 31, 2027
2 conditions
2 sponsors
1 location
NCT06302608
Safety and Efficacy Study of NGGT001 in Bietti Crystalline Corneoretinal Dystrophy
EARLY_PHASE1
Active, not recruiting
6 participants
Started: Feb 8, 2023 · Completed: May 29, 2028
1 condition
1 sponsor
1 location
NCT05355337
Pramipexole for Anhedonic Depression
PHASE3
Active, not recruiting
120 participants
Started: Feb 8, 2023 · Completed: Sep 30, 2025
3 conditions
2 sponsors
1 location
NCT05536804
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
PHASE2
Active, not recruiting
140 participants
Started: Feb 8, 2023 · Completed: Oct 31, 2026
5 conditions
1 sponsor
27 locations
NCT05578976
A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (R-CHOP) or R-CHOP in Adult Participants With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)
PHASE3
Active, not recruiting
900 participants
Started: Feb 8, 2023 · Completed: Dec 31, 2029
1 condition
1 sponsor
331 locations
NCT06266143
A Trial of Y101D in Combination With Gemcitabine and Albumin Paclitaxel in Patients With Advanced Pancreatic Cancer
PHASE1/PHASE2
Active, not recruiting
71 participants
Started: Feb 8, 2023 · Completed: Oct 20, 2025
1 condition
1 sponsor
1 location
NCT05873803
The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps
PHASE2
Active, not recruiting
70 participants
Started: Feb 8, 2023 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT06127238
Study of ST-1898 in Advanced Renal Cell Carcinoma
PHASE1/PHASE2
Active, not recruiting
90 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05705791
Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma
NA
Active, not recruiting
33 participants
Started: Feb 7, 2023 · Completed: Aug 31, 2026
1 condition
1 sponsor
6 locations
NCT06362174
Capsule & Omics for pRedicting Exacerbation of Crohn's Disease
N/A
Active, not recruiting
62 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06626750
Evaluating Stress Management Strategies Within the School Readiness Parenting Program
NA
Active, not recruiting
120 participants
Started: Feb 7, 2023 · Completed: May 29, 2026
5 conditions
1 sponsor
1 location
NCT05927623
Multifaceted Intervention Using Telehealth to Reduce the Risk of Falls and Fractures in Older Men
NA
Active, not recruiting
60 participants
Started: Feb 7, 2023 · Completed: Mar 31, 2026
6 conditions
2 sponsors
5 locations
NCT05520723
Preventive stRategy for IMMU132-relatED AEs in TNBC - PRIMED
PHASE2
Active, not recruiting
50 participants
Started: Feb 7, 2023 · Completed: Dec 14, 2025
2 conditions
2 sponsors
10 locations
NCT05548556
A Study to Evaluate RO7204239 in Participants With Facioscapulohumeral Muscular Dystrophy
PHASE2
Active, not recruiting
48 participants
Started: Feb 7, 2023 · Completed: Nov 2, 2026
1 condition
1 sponsor
10 locations
NCT05574491
Effectiveness of Traditional and Computerized Versions of Super Skills for Life in Children
NA
Active, not recruiting
105 participants
Started: Feb 7, 2023 · Completed: Dec 31, 2024
6 conditions
1 sponsor
1 location
NCT05797896
Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study
N/A
Active, not recruiting
250 participants
Started: Feb 7, 2023 · Completed: Jul 31, 2027
7 conditions
1 sponsor
22 locations
NCT05605535
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
PHASE2
Active, not recruiting
88 participants
Started: Feb 7, 2023 · Completed: Sep 15, 2027
5 conditions
2 sponsors
14 locations
NCT05767723
Platelet Sub-study of the Neomindset Trial
PHASE4
Active, not recruiting
48 participants
Started: Feb 6, 2023 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05737030
Effect of L-ornithine-L-aspertate (LOLA) on the Gut Microbiome
PHASE4
Active, not recruiting
55 participants
Started: Feb 6, 2023 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT06159309
Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients
N/A
Active, not recruiting
200 participants
Started: Feb 6, 2023 · Completed: Aug 31, 2025
4 conditions
1 sponsor
6 locations
NCT05760989
TRISCEND JAPAN Study
NA
Active, not recruiting
45 participants
Started: Feb 6, 2023 · Completed: Sep 30, 2029
3 conditions
1 sponsor
8 locations
NCT05074030
EMA/EMI for Psychiatrically Hospitalized Emerging Adults Who Drink to Cope
NA
Active, not recruiting
60 participants
Started: Feb 6, 2023 · Completed: Oct 1, 2025
1 condition
2 sponsors
1 location
NCT05528419
Sacubitril Valsartan in Preventing the Recurrence of Atrial Fibrillation After Ablation in Elderly Hypertensive Patients With Atrial Fibrillation
PHASE4
Active, not recruiting
320 participants
Started: Feb 6, 2023 · Completed: Jun 1, 2026
2 conditions
1 sponsor
1 location
NCT05660447
A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR
PHASE2/PHASE3
Active, not recruiting
80 participants
Started: Feb 6, 2023 · Completed: Jan 31, 2025
2 conditions
1 sponsor
1 location
NCT05602766
Ngenla Subcutaneous Injection Special Investigation
N/A
Active, not recruiting
1 participants
Started: Feb 6, 2023 · Completed: Apr 6, 2029
1 condition
1 sponsor
1 location
NCT05666804
Study Assessing the Efficacy and Safety of a Personalized Monotherapy Regimen of Brolucizumab in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy
PHASE3
Active, not recruiting
148 participants
Started: Feb 6, 2023 · Completed: Oct 31, 2025
1 condition
1 sponsor
15 locations
NCT05722444
Sleep and Health Outcomes in Women With Heavy Menses
NA
Active, not recruiting
25 participants
Started: Feb 6, 2023 · Completed: May 31, 2024
1 condition
1 sponsor
1 location
NCT05826171
Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia
NA
Active, not recruiting
20 participants
Started: Feb 6, 2023 · Completed: May 31, 2025
5 conditions
1 sponsor
1 location
NCT03909321
Beach Tennis And Hypertension Study 2
NA
Active, not recruiting
42 participants
Started: Feb 6, 2023 · Completed: Mar 1, 2024
1 condition
2 sponsors
1 location
NCT05560399
A Study of Iberdomide (CC-220) in Combination With Elotuzumab and Dexamethasone for Relapsed/Refractory Multiple Myeloma
EARLY_PHASE1
Active, not recruiting
7 participants
Started: Feb 6, 2023 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT06544213
A 60 Days Head Down Tilt Bedrest With Artificial Gravity and Cycling Exercise on 24 Healthy Male (BRACE)
NA
Active, not recruiting
24 participants
Started: Feb 6, 2023 · Completed: Apr 30, 2026
2 conditions
3 sponsors
1 location
NCT06635434
An English/Spanish Mobile Augmented Reality Pain Assessment App for Hispanic/Latino Pediatric Cancer Patients
EARLY_PHASE1
Active, not recruiting
16 participants
Started: Feb 5, 2023 · Completed: Nov 30, 2024
2 conditions
2 sponsors
1 location
NCT05562622
Assessment of DOT Spectacles in Chinese Children
NA
Active, not recruiting
195 participants
Started: Feb 5, 2023 · Completed: Mar 31, 2026
2 conditions
1 sponsor
5 locations
NCT06095271
MultiSCRIPT-Cycle 1: Personalized Medicine in Multiple Sclerosis - Pragmatic Platform Trial Embedded Within the SMSC
NA
Active, not recruiting
920 participants
Started: Feb 5, 2023 · Completed: May 31, 2027
1 condition
1 sponsor
8 locations
NCT05724329
Neoadjuvant Tislelizumab in Combination With Dasatinib and Quercetin in Resectable HNSCC (COIS-01)
PHASE2
Active, not recruiting
24 participants
Started: Feb 5, 2023 · Completed: Aug 5, 2028
1 condition
1 sponsor
1 location
Previous
1
More pages
138
139
140
141
142
143
144
More pages
431
Next